Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267501 · ClinicalTrials.gov registry record
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
A clinical trial of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00267501: Recruiting study of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT00267501 is a study of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 5,000 participants, above the 670-participant average among 17 other Food Allergy trials with a reported enrollment target (646% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00267501, a study of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2005-05 |
| Est. Completion | 2050-01 |
What NCT00267501 shows while recruiting
NCT00267501 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 670-participant average among 17 other Food Allergy trials with a reported enrollment target (646% higher).
The record links to 2 conditions, with Food Allergy appearing as the primary indexed condition, and to 0 interventions.
NCT00267501 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00267501 about?
NCT00267501 is a clinical study titled "Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders". The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.
What is the current status of trial NCT00267501?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2005-05. Estimated completion is 2050-01.
What conditions does trial NCT00267501 study?
This clinical trial studies the following conditions: Food Allergy, Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease.
Who is sponsoring clinical trial NCT00267501?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00267501 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00267501's enrollment target sits among peer trials
5,000 2nd of 17 the highest of 17 other Food Allergy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Food Allergy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Omalizumab in the Skin of Food Allergy Patients
RECRUITING · Phase 4
-
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
RECRUITING · Phase 1
-
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
RECRUITING · Phase 2
-
Natural History and Genetics of Food Allergy and Related Conditions
RECRUITING
-
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
RECRUITING · NA
-
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia